Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical jujube, tarragon, combination gel, lidocaine, and placebo gel for pain during inferior alveolar nerve block needle insertion
IRCT20241115063712N1Phase 3Completed
- Sponsor
- Mazandaran University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, triple-blind trial of jujube extract and lidocaine in None (5 arms), sponsored by Mazandaran University of Medical Sciences. Primary endpoint: Pain caused by needle insertion. Started Dec 2024; status: completed.
02
Drugs
jujube extractlidocaine
Beyond the preview
Go deeper on IRCT20241115063712N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241115063712N1.